Alcon Ag Stock Today
| ALC Stock | USD 88.96 2.15 2.48% |
PerformanceModest
| Odds Of DistressVery Low
|
Alcon AG is trading at 88.96 as of the 16th of March 2025, a 2.48 percent increase since the beginning of the trading day. The stock's open price was 86.81. Alcon AG has a very small chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Note, on November 15, 2019, Representative Debbie Dingell of US Congress acquired under $15k worth of Alcon AG's common stock.
Business Domain Health Care Equipment & Services | IPO Date 9th of April 2019 | Category Healthcare | Classification Health Care |
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland. Alcon operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. The company has 494.62 M outstanding shares of which 3.5 M shares are presently shorted by investors with about 2.01 days to cover. More on Alcon AG
Moving together with Alcon Stock
Moving against Alcon Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Alcon Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | David Endicott | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Alchemia S.A. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, Swiss Leader Price, Swiss Market Index, Swiss Leader TR, SPASX All Technology, Australia All Ordinaries, Swiss Performance Index, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAlcon AG can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Alcon AG's financial leverage. It provides some insight into what part of Alcon AG's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Alcon AG (ALC) is traded on New York Stock Exchange in USA. It is located in Chemin de Blandonnet 8, Geneva, Switzerland, 1214 and employs 25,599 people. Alcon AG is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 44 B. Alcon AG runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 494.62 M outstanding shares of which 3.5 M shares are presently shorted by investors with about 2.01 days to cover.
Alcon AG has about 1.03 B in cash with 2.08 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.1.
Check Alcon AG Probability Of Bankruptcy
Ownership AllocationAlcon AG holds a total of 494.62 Million outstanding shares. The majority of Alcon AG outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Alcon AG to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Alcon AG. Please pay attention to any change in the institutional holdings of Alcon AG as this could imply that something significant has changed or is about to change at the company. Please note that on November 15, 2019, Representative Debbie Dingell of US Congress acquired under $15k worth of Alcon AG's common stock.
Check Alcon Ownership Details
Alcon Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| T. Rowe Price Investment Management,inc. | 2024-12-31 | 6.4 M | |
| Ako Capital Llp | 2024-12-31 | 5.9 M | |
| Ubs Group Ag | 2024-12-31 | 5.8 M | |
| Clearbridge Advisors, Llc | 2024-12-31 | 5.2 M | |
| Amundi | 2024-12-31 | 4.5 M | |
| Pictet Asset Manangement Sa | 2024-12-31 | 4.2 M | |
| Legal & General Group Plc | 2024-12-31 | 4.1 M | |
| Marshall Wace Asset Management Ltd | 2024-12-31 | 4.1 M | |
| Bank Of America Corp | 2024-12-31 | 4.1 M | |
| Vanguard Group Inc | 2024-12-31 | 19.6 M | |
| Fmr Inc | 2024-12-31 | 15 M |
Alcon AG Historical Income Statement
Alcon Stock Against Markets
Alcon AG Corporate Management
| Royce Bedward | General VP | Profile | |
| Dieter Spaelti | Independent Director | Profile | |
| Daniel Cravens | Vice Relations | Profile | |
| Michael Onuscheck | President - Global Businesses and Innovation | Profile | |
| Ed McGough | Senior Operations | Profile |
Already Invested in Alcon AG?
The danger of trading Alcon AG is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Alcon AG is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Alcon AG. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Alcon AG is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Alcon AG offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alcon AG's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alcon Ag Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alcon Ag Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alcon AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Alcon Stock refer to our How to Trade Alcon Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alcon AG. If investors know Alcon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alcon AG listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.34) | Dividend Share 0.309 | Earnings Share 2.05 | Revenue Per Share | Quarterly Revenue Growth 0.064 |
The market value of Alcon AG is measured differently than its book value, which is the value of Alcon that is recorded on the company's balance sheet. Investors also form their own opinion of Alcon AG's value that differs from its market value or its book value, called intrinsic value, which is Alcon AG's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alcon AG's market value can be influenced by many factors that don't directly affect Alcon AG's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alcon AG's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alcon AG is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alcon AG's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.